Product Code: QCX FDA class 2 21 CFR 868.5095

Retrograde Intubation Set

Anesthesiology

The Retrograde Intubation Set is a prescription device used to perform retrograde intubation via the cricothyroid membrane, and may contain or be labeled for use with guidewires and intubating catheters, needles, syringes, and hemostats. It is classified as FDA Class 2, requiring 510(k) premarket notification, and is eligible for third-party review. The product code is QCX under regulation 868.5095 in the Anesthesiology specialty. It is not an implant and is not life-sustaining.

510(k)s
1
FEI Numbers
2
Registration Numbers
2
Unique Applicants
1
Years Active

Research product code QCX in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
QCX
Device Class
FDA class 2
Regulation Number
868.5095
Medical Specialty
Anesthesiology
Review Panel
AN
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

Definition

A retrograde intubation device is a prescription device used to perform retrograde intubation via the cricothyroid membrane. The device may contain or be labeled for use with guidewires and intubating catheters, in addition to needles (21 CFR 8685090), syringe (21 CFR 880.5860), and hemostats (21 CFR 878.4800).

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 1 510(k) clearance via K numbers.

K Number Device Name
DEN170055 Retrograde Intubation Set

FEI Numbers

This FDA classification entry is associated with 2 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 2 registration numbers. Click on an entry to view related FDA registrations.